FDA
-
-
-
-
-
-
-
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025
-
-
-
-
-
-
-
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC
-
-
-
-
-
-
-
Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health
-
-
-
-
-
-
-
Hologic Announces Financial Results for First Quarter of Fiscal 2024
-
-
-
-
-
-
-
Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
-
-
-
-
-
-
-
New Data Presented at SABCS 2022 Reveal Expanded Predictive Value of the Breast Cancer Index™ Test for Ovarian Function Suppression in Premenopausal Women with HR+ Breast Cancer
-
-
-
-
-
-
-
Hologic (HOLX) Granted FDA Approval of Aptima CMV Quant Assay for Human Cytomegalovirus
-
324,764 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

